Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients
Pilot Study for Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients
On the EAU (European Association of Urology) guidelines, the ulcer type bladder pain syndrome (BPS) should be treated with transurethral resection (TUR) or coagulation (TUC) of ulcer.
But, Up to date, there was no study to compare the therapeutic efficacy of TUR with TUC in ulcer type BPS patients.
We assume TUR have a more therapeutic effect than TUC.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Samsung Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male and female aged 18 yrs or greater
- Patients diagnosed with BPS(Bladder Pain Syndrome)
- Symptom persisted more than 6 months
- Pain VAS ≥4
- O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) scores 12 or greater with pain and nocturia domain scores > 2.
- Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF) >13
- No history of cystoscopy within 2yrs.
Exclusion Criteria:
- History of augmentation cystoplasty or previous transurethral coagulation/resection due to BPS
- Child-bearing potential, pregnant or nursing women.
- Mean voided volume lesser than 40ml or over than 400ml.
- Hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.
- Urinary tract infection during run-in periods.
- Genitourinary tuberculosis or bladder,urethral and prostate cancer
- Recurrent urinary tract infection
- History of hysterectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate operation or treatment etc within 6months.
- Neurologic disease history of cerebral infarction,multiple sclerosis or parkinsonism etc.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Transurethral Coagulation (TUC)
This cohort patients will be managed with Transurethral Coagulation (TUC) of IC ulcer lesion
|
|
|
Transurethral Resection(TUR)
This cohort patients will be managed with transurethral resection(TUR) of IC ulcer lesion
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Recurrence-free survival between TUC and TUR
Time Frame: Until 12 months after the last subject be enrolled
|
Until 12 months after the last subject be enrolled
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The change of voiding dairy parameters(mean number of micturition,Urgency etc) after each treatment
Time Frame: 1,3,6,9 and 12 months
|
1,3,6,9 and 12 months
|
|
The change of Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF)
Time Frame: 1,3,6,9 and 12months.
|
1,3,6,9 and 12months.
|
|
The change of Global Response Assessment(GRA) score
Time Frame: 1,3,6,9 and 12 months
|
1,3,6,9 and 12 months
|
|
The change of EQ-5D (EuroQOL five dimensions) Health Questionnaire score
Time Frame: 1,3,6,9 and 12months
|
1,3,6,9 and 12months
|
|
The change of Patient Global Assessment(PGA)
Time Frame: 12months
|
12months
|
|
The change of Brief Pain Inventory-short form(BPI-sf) score
Time Frame: 9 and 12months
|
9 and 12months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2013-05-127
- ksleedr (Other Identifier: Samsung Medical Center)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.